Thrivent Financial for Lutherans raised its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 31.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,609 shares of the company's stock after acquiring an additional 9,618 shares during the quarter. Thrivent Financial for Lutherans' holdings in Doximity were worth $2,169,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. FMR LLC grew its position in Doximity by 30.5% during the third quarter. FMR LLC now owns 6,837,733 shares of the company's stock valued at $297,920,000 after purchasing an additional 1,598,602 shares in the last quarter. State Street Corp boosted its stake in shares of Doximity by 2.5% during the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company's stock valued at $160,947,000 after buying an additional 88,922 shares during the period. Geode Capital Management LLC grew its holdings in shares of Doximity by 19.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company's stock valued at $124,503,000 after acquiring an additional 472,565 shares in the last quarter. Los Angeles Capital Management LLC increased its stake in shares of Doximity by 33.7% in the fourth quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company's stock worth $46,466,000 after acquiring an additional 219,448 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Doximity by 3.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 778,524 shares of the company's stock worth $41,565,000 after acquiring an additional 25,523 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.
Analysts Set New Price Targets
Several research analysts have weighed in on DOCS shares. Wells Fargo & Company reaffirmed an "equal weight" rating on shares of Doximity in a research report on Friday, February 7th. Needham & Company LLC increased their price objective on Doximity from $65.00 to $82.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Mizuho raised their price objective on shares of Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Piper Sandler raised shares of Doximity from a "neutral" rating to an "overweight" rating and boosted their target price for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Finally, KeyCorp cut their price target on shares of Doximity from $70.00 to $65.00 and set an "overweight" rating on the stock in a report on Wednesday, January 8th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $64.22.
Get Our Latest Report on DOCS
Insider Activity at Doximity
In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 37.40% of the company's stock.
Doximity Stock Performance
Shares of NASDAQ:DOCS traded up $1.24 on Wednesday, hitting $57.96. 1,819,929 shares of the company were exchanged, compared to its average volume of 1,940,780. The company's 50 day moving average price is $65.63 and its two-hundred day moving average price is $54.84. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21. The firm has a market capitalization of $10.82 billion, a price-to-earnings ratio of 57.96, a PEG ratio of 4.10 and a beta of 1.34.
About Doximity
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Recommended Stories

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.